Table of Contents Table of Contents
Previous Page  142 / 464 Next Page
Information
Show Menu
Previous Page 142 / 464 Next Page
Page Background

142

SCIENTIFIC PROGRAMME

| Programme and Exhibition Guide

MONDAY 8 MAY 2017

15:45 > Standard treatment in anal cancer: where do we stand and where should

we go?

Speaker: R. Muirhead (UK)

SP-0471

JOINT SYMPOSIUM

ESTRO-RANZCR: Big data to better radiotherapy

14:45 - 16:15 | STOLZ 1-2

This session covers the topic of Big Data to Better Radiotherapy from the standpoints

of data collection and interpretation, types of datasets (genetic, dosimetric, clinical),

application of big datasets in the settings of planning and radiotherapy delivery, and

the potential clinical gains in cancer patient care arising from these.

Highlights of the international expert panel talks include:

• How big data compliments/differs from traditional clinical trial research

• The challenges and processed in big data collection

• New opportunities in the field of radiogenomics

• Big data in improving plan quality and automation

• Translating what we learn from big data to the clinical setting and individual

patient care

Chair: J. Alsner (Denmark)

Chair: S. Turner (Australia)

14:45 > The pros, cons, process and challenges for achieving better radiotherapy

through data -an introduction

Speaker: L.C. Holloway (Australia)

SP-0472

15:07 > From genomics and radiogenomics data to a better RT

Speaker: A. Vega (Spain)

SP-0473

15:29 > From radiotherapy and dosimetry data to better plans

Speaker: M. Hoogeman (The Netherlands)

SP-0474

15:51 > Moving big data into clinical practice – a positive outlook

Speaker: S. Vinod (Australia)

SP-0475

SYMPOSIUM

Locally advanced breast cancer

14:45 - 16:15 | SCHUBERT

Patients with breast cancer showing unfavourable prognostic factors, either

related to tumour extent or molecular subtype, use to have a multimodality